文献速递血栓与止血

血小板对红内期疟原虫感染激活致病性反应而非保护性免疫反应

Platelets activate a pathogenic response to blood-stage Plasmodium infection but not a protective immune response.
PubMed 文献 · Blood · 2017-01-17

研究通过小鼠模型和体外实验探讨血小板在红内期疟原虫感染中的作用。去除血小板、抑制血小板或过继转移野生型血小板均不影响疟原虫血症;血小板与感染红细胞的结合率低于10%,凋亡疟原虫感染红细胞结合血小板极少。过继转移野生型血小板至CD40基因敲除小鼠部分恢复了实验性脑型疟疾的死亡率和症状,表明血小板通过CD40分子诱发致病性反应而非杀灭疟原虫。

要点

  • 去除血小板、阿司匹林抑制血小板或过继转移野生型血小板均不改变疟原虫血症水平。
  • 生理比例下人血小板不抑制红内期恶性疟原虫的体外发育或复制。
  • 过继转移野生型血小板至CD40敲除小鼠部分恢复实验性脑型疟疾死亡率和症状。

核心结论

  • 血小板在生理相关效应靶比下不杀灭红内期疟原虫,保护性免疫反应的激活不需要血小板,但血小板通过CD40分子诱发致病性反应。

研究设计与样本

  • 研究采用小鼠模型(伯氏疟原虫和夏氏疟原虫感染)及体外恶性疟原虫培养实验,结合抗CD41单克隆抗体去除血小板、阿司匹林抑制血小板和过继转移野生型血小板至CD40基因敲除小鼠等方法。

主要发现

  • 抗CD41单克隆抗体去除血小板、阿司匹林抑制血小板及过继转移野生型血小板至CD40敲除小鼠后,疟原虫血症与对照组小鼠相似。
  • 人血小板与红细胞按1:9的生理比例共培养,不抑制红内期恶性疟原虫的体外发育或复制。
  • 在夏氏疟原虫和伯氏疟原虫感染小鼠疟原虫血症上升期及恶性疟原虫48小时体外周期中,结合血小板的感染红细胞百分比低于10%。
  • 夏氏疟原虫和伯氏疟原虫感染红细胞中,凋亡疟原虫(TdT阳性)者血小板结合极少(低于5%),与非凋亡感染红细胞相似。
  • 在感染前即刻用单克隆抗体去除血小板的小鼠中,夏氏疟原虫初次和二次疟原虫血症与对照相似。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Clinical studies indicate that thrombocytopenia correlates with the development of severe falciparum malaria, suggesting that platelets either contribute to control of parasite replication, possibly as innate parasite killer cells or function in eliciting pathogenesis. Removal of platelets by anti-CD41 mAb treatment, platelet inhibition by aspirin, and adoptive transfer of wild-type (WT) platelets to CD40-KO mice, which do not control parasite replication, resulted in similar parasitemia compared with control mice. Human platelets at a physiologic ratio of 1 platelet to 9 red blood cells (RBCs) did not inhibit the in vitro development or replication of blood-stage Plasmodium falciparum The percentage of Plasmodium-infected (iRBCs) with bound platelets during the ascending parasitemia in Plasmodium chabaudi- and Plasmodium berghei-infected mice and the 48-hour in vitro cycle of P falciparum was <10%. P chabaudi and P berghei iRBCs with apoptotic parasites (TdT+) exhibited minimal platelet binding (<5%), which was similar to nonapoptotic iRBCs. These findings collectively indicate platelets do not kill bloodstage Plasmodium at physiologically relevant effector-to-target ratios. P chabaudi primary and secondary parasitemia was similar in mice depleted of platelets by mAb-injection just before infection, indicating that activation of the protective immune response does not require platelets. In contrast to the lack of an effect on parasite replication, adoptive transfer of WT platelets to CD40-KO mice, which are resistant to experimental cerebral malaria, partially restored experimental cerebral malaria mortality and symptoms in CD40-KO recipients, indicating platelets elicit pathogenesis and platelet CD40 is a key molecule.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Gramaglia I, Velez J, Combes V, et al. Platelets activate a pathogenic response to blood-stage Plasmodium infection but not a protective immune response. Blood. 2017. PMID: 28096086. doi:10.1182/blood-2016-08-733519

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。